BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Semb S, Helgstrand F, Hjørne F, Bytzer P. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication. World J Gastroenterol 2017; 23(37): 6907-6910 [PMID: 29085234 DOI: 10.3748/wjg.v23.i37.6907]
URL: https://www.wjgnet.com/1007-9327/full/v23/i37/6907.htm
Number Citing Articles
R. Kettritz, F. C. Luft. Seltene ElektrolytstörungenDer Nephrologe 2019; 14(2): 94 doi: 10.1007/s11560-018-0278-7
嘉豪 李. Common Adverse Reactions and Corresponding Management Measures of Cisplatin Combined with Gemcitabine in ChemotherapyAdvances in Clinical Medicine 2023; 13(12): 19087 doi: 10.12677/ACM.2023.13122684
Zuber Khan, Sidharth Mehan, Mohd. Anas Saifi, Ghanshyam Das Gupta, Acharan S. Narula, Reni Kalfin. Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the Dementia Connection and Co-morbid RisksCurrent Alzheimer Research 2023; 20(11): 739 doi: 10.2174/0115672050289946240223050737
Rohit Tayal, Sabina Yasmin, Samrat Chauhan, Thakur Gurjeet Singh, Monika Saini, Eman Shorog, Maryam M. Althubyani, Baiaan H. Alsaadi, Fatimah Aljohani, Maram A. Alenazi, Sarah A. Abutaily, Mohammad Yousuf Ansari. Are Proton Pump Inhibitors Contributing in Emerging New Hypertensive Population?Pharmaceuticals 2023; 16(10): 1387 doi: 10.3390/ph16101387
OmeprazoleReactions Weekly 2018; 1710(1): 244 doi: 10.1007/s40278-018-48916-z
Ho Seok Seo, Miyoung Choi, Sang-Yong Son, Min Gyu Kim, Dong-Seok Han, Han Hong Lee. Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018Journal of Gastric Cancer 2018; 18(4): 313 doi: 10.5230/jgc.2018.18.e41
Pim M. W. Janssens, Michiel W. Pot, Moniek Wouters, Henk J. van Leeuwen, Marcel M. G. J. van Borren. What extreme laboratory values can be obtained that (some) patients can survive with?Scandinavian Journal of Clinical and Laboratory Investigation 2022; 82(1): 50 doi: 10.1080/00365513.2021.2015800
Arun Koyyada. Long-term use of proton pump inhibitors as a risk factor for various adverse manifestationsTherapies 2021; 76(1): 13 doi: 10.1016/j.therap.2020.06.019
Jinfeng Zhang, Mingxi Lin, Yizi Jin, Linhan Gu, Ting Li, Baoying Yuan, Biyun Wang, Leiping Wang, Sheng Zhang, Jun Cao, Zhonghua Tao, Jian Zhang, Xichun Hu. Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemiaBreast Cancer Research and Treatment 2020; 182(3): 719 doi: 10.1007/s10549-020-05730-2
Paola Cabras, Michele Anedda, Laura Caddeo, Marongiu Francesco, Mameli Antonella. Hypomagnesemia and Hypocalcemia Caused by Proton-Pump Inhibitors Long-Term TherapyAmerican Journal of Therapeutics 2020; 27(6): e676 doi: 10.1097/MJT.0000000000001041